29 Jul A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain
The EN 20-01 study is testing a new investigational medication, called CNTX-6970, to see if it is helpful and safe for patients with knee osteoarthritis pain. CNTX-6970 is being developed as a new treatment for chronic pain, including painful osteoarthritis of the knee. This medication is not yet approved by the FDA.
Study participation lasts approximately 6 months and includes 11 visits to the University of Washington Medical Center. If interested, please call Shannon at 206-685-1031 or email uwkneepainstudy@uw.edu. Dr. Stacey is the Site Principal Investigator for this research study at the University of Washington.
ClinicalTrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT05025787?term=NCT05025787&draw=2&rank=1
Participant Eligibility
Age 40 to 90 years old
Painful knee osteoarthritis
Willing to come to UWMC every few weeks for 6 months to participate in the study visits
Contact
Shannon Jajko
(206) 685-1031
Additional Study Details
Full Study Title
EN 20-01: A 24-WEEK STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CNTX-6970 IN SUBJECTS WITH MODERATE TO SEVERE KNEE OSTEOARTHRITIS PAIN
Investigator(s)
Brett Stacey, MD
Michele Curatolo, MD, PhD
Accepts Healthy Volunteers?
No
Study Site(s)
University of Washington Medical Center – Montlake
1959 NE Pacific St
Seatte, Washington 98195
